What is an indication for glucagon-like peptide-1 (GLP-1) agonists?

A. Assessment: Asking about medication allergies is part of the data-gathering phase of the nursing process. This step involves collecting subjective and objective information to identify factors that may affect pharmacologic safety, including hypersensitivity reactions or previous adverse responses that could contraindicate medication therapy.

B. Implementation: Implementation refers to carrying out interventions such as administering medications or providing teaching. Since the nurse is gathering information rather than performing an intervention, this phase is not being used.

C. Planning: Planning involves developing goals and selecting interventions based on assessment data. The nurse cannot begin planning until allergy information and other relevant data have already been collected, so this step does not apply.

D. Diagnosis: Nursing diagnosis involves analyzing assessment data to identify client problems or risks. Asking about allergies occurs before this analytical step and therefore belongs to the assessment phase.

A. Before dinner: Taking levothyroxine before dinner is not recommended because food can interfere with absorption, reducing the medication’s effectiveness. Evening administration may also disrupt sleep due to its stimulant effects in some clients.

B. At bedtime: While some clients may take levothyroxine at night if instructed, it is generally less effective when taken with food or close to evening meals. Standard practice favors morning dosing on an empty stomach for optimal absorption.

C. With lunch: Food, especially those containing calcium, iron, or high fiber, can significantly impair levothyroxine absorption. Taking it with lunch decreases bioavailability and may prevent the client from achieving therapeutic effects.

D. Before breakfast: Administering levothyroxine first thing in the morning on an empty stomach, ideally 30–60 minutes before food or other medications, maximizes absorption and ensures consistent thyroid hormone levels, optimizing therapeutic outcomes.